Modifying plasmid-loaded HSA-nanoparticles with cell penetrating peptides – Cellular uptake and enhanced gene delivery
Authors:
- 1 April 2017
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 522 (1-2) , 198-209
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Ligand-Modified Human Serum Albumin Nanoparticles for Enhanced Gene DeliveryMolecular Pharmaceutics, 2015
- Gene therapy and DNA delivery systemsInternational Journal of Pharmaceutics, 2014
- Cellular Internalization of Quantum Dots Noncovalently Conjugated with Arginine-Rich Cell-Penetrating PeptidesJournal of Nanoscience and Nanotechnology, 2010
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticlesJournal of Controlled Release, 2008
- Gene therapy clinical trials worldwide to 2007—an updateThe Journal of Gene Medicine, 2007
- A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating PeptidesTraffic, 2007
- Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptidesAdvanced Drug Delivery Reviews, 2005
- Polymeric Gene CarriersCritical Reviews™ in Eukaryotic Gene Expression, 2005
- Nonviral gene therapy: promises and challengesGene Therapy, 2000
- Theory of the stability of strongly charged lyophobic sols and of the adhesion of strongly charged particles in solutions of electrolytesProgress in Surface Science, 1993